BOMXF yields 4.99% · PFE yields 6.13%● Live data
📍 BOMXF pulled ahead of the other in Year 1
Combined, BOMXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BOMXF + PFE for your $10,000?
Bolsa Mexicana de Valores, S.A.B. de C.V. operates cash, listed derivatives, and OTC markets for various asset classes, including equities, fixed income, and exchange traded funds. The company also provides custody, clearing and settlement facilities, and data products for the local and international financial community. It operates the Mexican Stock Exchange that provides facilities and mechanisms as an aid in the relationship of the securities supply and demand, credit certificates, and other documents registered at the National Securities Registry, as well as services for underwriting, offering, and the exchange of the aforementioned securities; and publishes, provides, and maintains information of the securities listed at the Mexican Exchange and at the International Quotations System to the general public. The company's exchange also issues regulation that sets standards, and operative and conduct guidelines to promote fair and equitable market practices at the securities market; and guards its observation and impose disciplinary and corrective measures in case of lack of fulfillment for brokerage firms and the issuers with listed securities at the Mexican Exchange. In addition, it offers central securities depository, custody and settlement of securities, clearing house, price valuation, and risk management services. The company is based in Mexico City, Mexico.
Full BOMXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.